Genetic Analysis AS (FRA:8V8) Total Assets : €4.65 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Total Assets?

Genetic Analysis AS's Total Assets for the quarter that ended in Dec. 2023 was €4.65 Mil.

During the past 12 months, Genetic Analysis AS's average Total Assets Growth Rate was -4.50% per year. During the past 3 years, the average Total Assets Growth Rate was 6.70% per year.

During the past 5 years, Genetic Analysis AS's highest 3-Year average Total Assets Growth Rate was 6.70%. The lowest was -1.30%. And the median was 2.70%.

Total Assets is connected with ROA %. Genetic Analysis AS's annualized ROA % for the quarter that ended in Dec. 2023 was -55.22%. Total Assets is also linked to Revenue through Asset Turnover. Genetic Analysis AS's Asset Turnover for the quarter that ended in Dec. 2023 was 0.08.

Genetic Analysis AS Total Assets Historical Data

The historical data trend for Genetic Analysis AS's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Total Assets Chart

Genetic Analysis AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

4.55

5.25

8.23

6.16

4.65

Genetic Analysis AS Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial										6.16	4.88	4.44	3.75	4.65

Genetic Analysis AS Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Genetic Analysis AS's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	2.781	+	1.868
	=	4.65

Genetic Analysis AS's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	2.781	+	1.868
	=	4.65

Genetic Analysis AS (FRA:8V8) Total Assets Explanation

Total Assets is connected with ROA %.

Genetic Analysis AS's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-2.32	/	( (3.752	+	4.65)	/ 2 )
	=	-2.32	/	4.201
	=	-55.22 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Genetic Analysis AS's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.33	/	( (3.752	+	4.65)	/ 2 )
=	0.33	/	4.201
=	0.08

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Genetic Analysis AS Total Assets Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (FRA:8V8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (FRA:8V8) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

GEAN:Sweden

Address

Kabelgata 8, Oslo, NOR, 0580

Website

https://www.genetic-analysis.com

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (FRA:8V8) Headlines

No Headlines